|
|
|
|
| |
 |
Gruppi di lavoro GOLD-Italia
| RESPONSABILI |
SOTTOGRUPPO |
|
| |
| Fabbri, Corbetta |
Definizione e classificazione di gravità |
|
|
| Viegi |
Epidemiologia |
|
|
| Saetta, Baraldo |
Anatomia patologica |
|
| |
|
|
|
| Sabato, Zuccaro |
Fattori di rischio |
|
| |
|
|
|
| Maestrelli |
Diagnosi funzionale |
- Ferguson G.T., Enright P.L., Buist A.S., Higgins M.W. Office Spirometry for Lung Health Assessment in Adults
- Glady C.A., Aaron S.D., Lunau M., Clinch J., Dales R.E. A Spirometry-Based Algorithm To Direct Lung Function Testing in the Pulmonary Function Laboratory. CHEST / 123 / 6 / JUNE, 2003
- Hardie J.A., Buist A.S., Vollmer W.M., Ellingsenz I., Bakkez P.S., Mørkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20: 1117–1122
- Proposta correzione Slide-Kit
- Proposta correzione Pocket Guide
|
 |
| Spanevello, Boschetto |
Diagnosi non funzionale |
- Madani A., Keyzer C., Gevenois P.A. Computed tomography assessment of lung structure and function in pulmonary emphysema. Eur Respir Mon, 2004, 30, 145–160.
- Parr D.G., Stoel B.C., Stolk J., Stockley R.A. Pattern of Emphysema Distribution in a1-Antitrypsin Deficiency Influences Lung Function Impairment Am J Respir Crit Care Med Vol 170. pp 1172–1178, 2004
- Patel I.S., Vlahos I., Wilkinson T.M.A., Lloyd-Owen S.J., Donaldson G.C., Wilks M., Reznek R.H., Wedzicha J.A. Bronchiectasis, Exacerbation Indices, and Inflammation in COPD. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 170 2004
- Vignola A.M., Paganin F., Capieu L., Scichilone N., Bellia M., Maakel L., Bellia V., Godard P., Bousquet J., Chanez P. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J 2004; 24: 910–917
- Fabbri L.M., Romagnoli M., Corbetta L., Casoni G., Busljetic K., Turato G., Ligabue G., Ciaccia A., Saetta M., Papi A. Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 167 2003
|
|
| Cocco, Vaghi |
Educazione del paziente e somministrazione dei farmaci |
| |
|
|
|
| Cazzola, Di Maria |
Trattamento BPCO stabile |
- Tennant R.C., Erin E.M., Barnes P.J.,Hansel T.T. Long-acting b2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified? Current Opinion in Pharmacology 2003, 3:270–276
- Szafranski W., Cukier A., Ramirez A., Menga G., Sansores R., Nahabedian S., Peterson S., Olsson H. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003; 21: 74–81
- Roth M., Johnson P.R.A., Rüdiger J.J., King G.G., Ge Q., Burgess J.K., Anderson G., Tamm M., Black J.L. Interaction between glucocorticoids and B2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. THE LANCET Vol 360 October 26, 2002
- Partridge M.R. Living with COPD: the patients' perspective. Eur Respir Rev 2004; 13: 88, 1–5
- Budesonide/formoterol proves its worth in COPD. Summary prepared by Adis Editors
- Reynolds N.A., Perry C.M., Keating G.M. Budesonide/Formoterol In COPD. Drugs 2004; 64 (4): 431-441 0012-6667/04/0004-0431/$34.00/0
- Cazzola M., Dahl R. Inhaled Combination Therapy With Long-Acting B2-Agonists and Corticosteroids in Stable COPD. CHEST / 126 / 1 / JULY, 2004
- Nannini L., Lasserson T.J., Poole P. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease. The Cochrane Library 2003, Issue 4
- Löfdahl C.G. Reducing the impact of COPD exacerbations: clinical efficacy of budesonide/formoterol. Eur Respir Rev 2004; 13: 88, 14–21
- Cazzola M., Santusb P., Di Marco F., Carlucci P., Mondoni M., Matera M.G., Centanni S. Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD. doi:10.1016/j.pupt.2004.01.001
- Calverley P.M., Boonsawat W., Cseke Z., Zhongz N., Peterson S., Olsson H. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 912–919
- Calverley P.M.A. Future expectations in COPD: measures of success. Eur Respir Rev 2004; 13: 88, 22–27
- Rabe K.F. Combination therapy for chronic obstructive pulmonary disease: one size fits all? Eur Respir J 2003; 22: 874–875
|
|
| Papi, Richeldi |
Trattamento riacutizzazioni |
|
|
| Corrado, Clini |
Trattamento dell'insufficienza respiratoria acuta e cronica |
- Carlucci A., Delmastro M., Rubini F., Fracchia C., Nava S. Changes in the practice of non-invasive ventilation in treating COPD patients over 8 years. Intensive Care Med (2003) 29:419–425 DOI 10.1007/s00134-002-1574-1
- Confalonieri M., Garuti G., Cattaruzza M.S., Osborn J.F., Antonelli M., Conti G., Kodric M., Resta1 O., Marchese S., Gregoretti C., Rossi A., A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J 2005; 25: 348–355 DOI: 10.1183/09031936.05.00085304
- Man W.D.C., Polkey M.I., Donaldson N., Gray B.J., Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ, doi:10.1136/bmj.38258.662720.3A
|
|
| Bettoncelli, Carnesalli |
Adattamento delle Linee Guida alla realtà della medicina Generale e raccomandazioni per la Diagnosi precoce in Medicina Generale |
| |
|
|
|
| Franchi |
Informazioni per i pazienti |
| |
|
|
|
| MATERIALE DIVULGATIVO |
|
PDF |
ZIP |
HTM |
|
|
|
|
| Slide-Kit |
-- |
-- |
|
| |
|
|
|
| Pocket Guide |
|
-- |
-- |
| |
|
|
|
| Guida per il paziente |
|
-- |
-- |
| |
|
|
|
| Doc. integrale 2003 - ITA |
|
|
-- |
| |
|
|
|
| Doc. integrale 2004 - ENG |
|
|
-- |
| |
|
|
|
| ERS ATS Giudelines |
|
-- |
-- |
|
|
|
|
 |
|
|
